Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Containing hepatitis C

W C Maddrey1

  • 1University of Texas Southwestern Medical Center at Dallas, USA.

Hospital Practice (1995)
|March 15, 1997
PubMed
Summary

Hepatitis C screening and improved diagnostics have reduced transmission, but millions remain infected. Current treatments may be unsuccessful but can slow liver damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe hepatitis from methyldopa.

Gastroenterology·2012
Same author

Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine.

Hepatology (Baltimore, Md.)·2001
Same author

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Journal of medical virology·2001
Same author

A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine.

Vaccine·2001
Same author

The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.

American journal of therapeutics·2001
Same author

Alcohol-induced liver disease.

Clinics in liver disease·2001

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection remains a significant global health concern.
  • Blood screening has dramatically reduced transfusion-associated HCV transmission.
  • Advances in diagnostic accuracy have improved early detection of HCV.

Observation:

  • Despite progress, millions worldwide are still infected with Hepatitis C.
  • Non-transfusional transmission routes for HCV persist.
  • Interferon-based therapies, while extended, show variable success rates.

Findings:

  • Improved diagnostic tests enhance the accuracy of Hepatitis C detection.
  • Longer interferon treatment regimens have led to better therapeutic responses in some patients.
  • Hepatitis C screening of donated blood has effectively curtailed a primary transmission pathway.

Implications:

  • Continued efforts are needed to address persistent transmission routes of Hepatitis C.
  • While often unsuccessful, current Hepatitis C treatments can mitigate liver destruction.
  • Further research into novel therapeutic strategies for Hepatitis C is crucial for public health.

Related Experiment Videos